Wergomet 0.2mg Injection
Marketer
Wockhardt Ltd
Salt Composition
Methylergometrine (0.2mg)
Overview Wergomet 0.2mg Injection
Uterine hemorrhage following childbirth or termination of pregnancy may be managed with Wergomet 0.2mg Injection. This medication acts on uterine smooth muscle, enhancing contractility (tone, rate, and amplitude) to minimize blood loss. Administration is strictly via intravenous or intramuscular injection by a healthcare professional in a hospital setting; self-administration is prohibited. Dosage and frequency are determined by your physician based on individual needs and the underlying condition. Treatment aims to alleviate symptoms as directed by your doctor. Headache, hypertension, and convulsions are potential side effects; report any concerning symptoms immediately. Strategies to mitigate or prevent side effects may be available. Alcohol consumption should be avoided during treatment. Prior to commencing therapy, inform your doctor of any pre-existing heart conditions or hypertension, and provide a complete list of all concurrent medications, as interactions may compromise efficacy or alter the drug's action.
Uses of Wergomet 0.2mg Injection
Hemorrhage postpartum
Major Benefits of Wergomet 0.2mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Wergomet 0.2mg Injection:
- High blood pressure
- Headache
- Seizure
How to use Wergomet 0.2mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Wergomet 0.2mg Injection works:
Wergomet 0.2mg Injection, derived from ergot alkaloids, induces prolonged uterine smooth muscle contractions. This vascular constriction effectively manages postpartum hemorrhage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Wergomet 0.2mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyUNSAFE
Administering Wergomet 0.2mg Injection to pregnant individuals poses a substantial risk. Pregnant women should consult their physician before use; research involving animals and pregnant women indicates considerable harm to the fetus.
Breast feedingCAUTION
Administering Wergomet 0.2mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingCONSULT YOUR DOCTOR
The effect of Wergomet 0.2mg Injection on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of 0.2mg Wergomet Injection to individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Data on Wergomet 0.2mg Injection use in individuals with hepatic impairment is scarce. Physician consultation is recommended.
What if you forget to take Wergomet 0.2mg Injection :
NA
Facts to Know About Wergomet 0.2mg Injection
| Label | Value |
|---|---|
| Chemical Type | Ergoline Alkaloids |
| Developing Habits | No. |
| Type of Therapy | Obstetrics and Gynecology |
| Actions | Drugs that induce uterine contractions and abortion |
3,018 People bought this recently